
AutOmics Biotechnology Inc. is developing a fully automated diagnostics platform that transforms raw tissue into actionable insights with minimal manual intervention. Their AI-driven system offers integrated multi-omics analysis (genome, epigenome, transcriptome, proteome) at the single-cell level, combined with whole-organ 3D spatial reconstruction. This revolutionary approach aims to eliminate misdiagnoses, provide 100x higher resolution than MRI, and accelerate research and clinical workflows by streamlining precision sectioning, multi-omics analysis, and spatial reconstruction. Their platform is designed for high sample throughput, comprehensive analysis of tissues of any size, and is compatible with both solid and liquid samples, ultimately advancing biomarker discovery and individualized precision medicine.

AutOmics Biotechnology Inc. is developing a fully automated diagnostics platform that transforms raw tissue into actionable insights with minimal manual intervention. Their AI-driven system offers integrated multi-omics analysis (genome, epigenome, transcriptome, proteome) at the single-cell level, combined with whole-organ 3D spatial reconstruction. This revolutionary approach aims to eliminate misdiagnoses, provide 100x higher resolution than MRI, and accelerate research and clinical workflows by streamlining precision sectioning, multi-omics analysis, and spatial reconstruction. Their platform is designed for high sample throughput, comprehensive analysis of tissues of any size, and is compatible with both solid and liquid samples, ultimately advancing biomarker discovery and individualized precision medicine.